Kite, a Gilead company, says the US Food and Drug Administration (FDA) has approved commercial production at the company’s new CAR T-cell therapy manufacturing facility in Frederick, Maryland.
Image: https://www.biopharma-reporter.com
{iframe}https://www.biopharma-reporter.com/Article/2022/04/19/Kite-s-Maryland-CAR-T-cell-therapy-site-gets-FDA-go-ahead{/iframe}